Pfenex Expression Technology platform is based on the microorganism, Pseudomonas fluorescens, for the production of research proteins, reagent proteins, biosimilars and innovator biopharmaceuticals. Under the multi-year agreement, Pfenex
The Fluidigm Access Array System is an automated sample preparation system for next-generation sequencing that provides parallel amplification of 48 unique samples, in effect preparing 48 sequencing libraries,
One of the independent venture capital firms participating in the Portfolio has acquired two molecules and will oversee the next stage of their development. The first is a
The Microcyn Technology platform is used to manufacture tissue care products which reduce the need for antibiotics while reducing infections and accelerating healing. The Microcyn Technology features a
Vasculotide is a synthetic peptide-based growth factor which targets Tie2, a receptor on specialized cells of the hematopoietic and vascular systems. Vasculotide was invented by Sunnybrook Research Institute
The Culex Automated In Vivo Sampling Services have long offered investigators a means to increase the amount and type of data gathered in drug discovery experiments with small
The Neglected Global Diseases Initiative at NGDI-UBC brings together the technical expertise and perspectives of a variety of disciplines at UBC – including bench science, pharmaceutical and health
The 10 products range initially within a dosage group of tablets and capsules with other dosage forms to follow. The buyer has placed an initial assorted order for
TheraBiogen received orders for zinc free nasal spray products from Imperial Distributors which operates across the Northeast and Mid-Atlantic states. Imperial Distributors will be supplying TheraMax to Big
In addition to the cash payment, each Genzyme shareholder will receive one contingent value right (CVR) for each share they own, entitling the holder to receive additional cash
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.